2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 3
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Cisplatin
1519
Carboplatin
1420
Cyclophosphamide
1362
Gemcitabine
1235
Bevacizumab
1226
Paclitaxel
1214
Radiotherapy
1176
Docetaxel
1080
pembrolizumab
1029
Oxaliplatin
936
Capecitabine
902
Fluorouracil
833
Rituximab
729
Doxorubicin
684
Nivolumab
679
Dexamethasone
667
Etoposide
660
Irinotecan
622
Leucovorin
576
Pemetrexed
510
Drug Therapy
493
Cetuximab
483
Trastuzumab
470
Cytarabine
467
Magnetic Resonance Spectroscopy
461
Filgrastim
446
Prednisone
433
Specimen Handling
411
Lenalidomide
410
Vincristine
400
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
AIEOP acute lymphoblastic leukemia protocol
×
Clear all
NCT06184009
2025-06-08
HR ALL
Seoul St. Mary's Hospital
Phase 2
Recruiting
370 enrolled